For the millions of people managing chronic liver disease while also struggling with alcohol use disorder, finding an effective, scalable intervention has remained a persistent clinical gap. A new randomized controlled trial published in Hepatology offers partial but meaningful evidence that a structured telehealth approach can move the needle on drinking reduction — though not as dramatically as hoped.
The trial enrolled 157 patients with chronic liver disease and unhealthy alcohol use across three healthcare systems, including Veterans Affairs and safety-net hepatology clinics. Nearly half had cirrhosis, and over a third had experienced decompensation — meaning their liver disease had already progressed to a dangerous stage. Participants were randomized to a stepped alcohol treatment (SAT) protocol or usual care. SAT began with three motivational interviewing sessions, escalating to addiction medicine referral if no reduction was seen at three months. While SAT failed to beat usual care on the primary outcome — achieving drinking below moderate levels — it did produce statistically significant reductions in drinks per week at both three and six months (effect estimate approximately -0.67, p=0.03), and this held up in multivariable modeling. Abstinence rates at six months trended toward SAT (29% vs. 18%), though this did not reach significance.
This trial is notable for its pragmatic real-world design — recruiting from safety-net and VA settings where liver disease burden is high and addiction care integration is inconsistent. The finding that baseline motivation predicted treatment response reinforces motivational interviewing's conceptual foundation but also highlights a ceiling problem: patients not yet motivated are likely undertreated by this protocol. The modest effect sizes and the absence of a significant primary outcome suggest this intervention is incremental rather than transformative. Clinicians should view stepped telehealth care as a viable add-on to usual hepatology care, particularly for patients who already express readiness to change, rather than a standalone solution for severe alcohol use disorder complicating liver disease.